Bafna Pharma Corporate Filings & Announcements

Latest corporate announcements and filings from Bafna Pharma on BSE

Search Inside the pdf :

Bafna Pharmaceuticals Ltd.

15 Apr 2026

136.02

-0.73%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Clarification On Price Movement

BSE India

We hereby submit our response to the Clarification sought by the Stock Exchange regarding the movement in the Share Price of the Company.

pdf

Bafna Pharmaceuticals Ltd.

13 Apr 2026

136.02

-0.73%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Clarification sought from Bafna Pharmaceuticals Ltd

BSE India

The Exchange has sought clarification from Bafna Pharmaceuticals Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Bafna Pharmaceuticals Ltd.

13 Apr 2026

136.02

-0.73%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of SEBi (DP) Regulations, 2018 for the Quarter ended March 31, 2026.

pdf

Bafna Pharmaceuticals Ltd.

27 Mar 2026

136.02

-0.73%

Corp. Note

Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Outcome for Outcome For Board Meeting Held On …

BSE India

The Board of Directors of the Company in the Meeting held on March 27, 2026 has inter-alia considered and approved: (i) The appointment of M/s. K. S. Rao & Co., Chartered Accountants, Chennai as the Internal Auditor of the Company for the Financial Year 2026-2027; (ii) The appointment of M/s. N. Sivashankaran & Co., Cost Accountants, Chennai as the Cost Auditor of the Company for the Financial Year 2026-2027.

pdf

Bafna Pharmaceuticals Ltd.

26 Mar 2026

136.02

-0.73%

SAST

Bafna Pharmaceuticals Ltd - 532989 - Closure of Trading Window

BSE India

Intimation for Closure of Trading Window.

pdf

Bafna Pharmaceuticals Ltd.

24 Mar 2026, 11:49AM

136.02

-0.73%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Clarification On Price Movement

BSE India

We hereby submit our response to the clarification sought by the Stock Exchange regarding the movement in the share price of the Company.

pdf

Bafna Pharmaceuticals Ltd.

23 Mar 2026

136.02

-0.73%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Clarification sought from Bafna Pharmaceuticals Ltd

BSE India

The Exchange has sought clarification from Bafna Pharmaceuticals Ltd on March 23, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.

Bafna Pharmaceuticals Ltd.

14 Feb 2026

136.02

-0.73%

Company Update

Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter and Nine-Months ended December 31, 2025 as published in "Business Standard" and "Makkal Kural" on February 13, 2026.

pdf

Bafna Pharmaceuticals Ltd.

11 Feb 2026

136.02

-0.73%

Result

Bafna Pharmaceuticals Ltd - 532989 - Unaudited Financial Results For The Quarter And Nine Months Ended …

BSE India

The Board of Directors of the Company in their Meeting held on February 11, 2026 has inter-alia considered and approved the Un-Audited Financial Results of the Company along with the Limited Review Report, for the Quarter and Nine Months ended on December 31, 2025.

pdf

Bafna Pharmaceuticals Ltd.

11 Feb 2026

136.02

-0.73%

Board Meeting

Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Outcome for Outcome For The Board Meeting Held …

BSE India

The Board of Directors of the Company in the Meeting held on February 11, 2026 has inter-alia considered and approved the Unaudited Financial Results of the Company along with the Limited Review Report issued by the Statutory Auditors, for the Quarter and Nine-Months ended on December 31, 2025.

pdf

Is Bafna Pharmaceuticals Ltd. worth buying?

25 Votes:

Buy 68.0%

Sell 24.0%

Hold 8.0%